{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:45:23Z","timestamp":1775627123050,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["YQ2022H009"],"award-info":[{"award-number":["YQ2022H009"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2023H038"],"award-info":[{"award-number":["LH2023H038"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303233"],"award-info":[{"award-number":["82303233"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8247101308"],"award-info":[{"award-number":["8247101308"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022MD723779"],"award-info":[{"award-number":["2022MD723779"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010009","name":"Heilongjiang Provincial Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["LBH-Z21024"],"award-info":[{"award-number":["LBH-Z21024"]}],"id":[{"id":"10.13039\/501100010009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012548","name":"Heilongjiang Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012548","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116885","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:32:13Z","timestamp":1744288333000},"page":"116885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Integrated network pharmacology and RNA sequencing analysis to reveal the mechanisms of Qici Sanling decoction in the treatment of gemcitabine resistant bladder cancer"],"prefix":"10.1016","volume":"262","author":[{"given":"Zhuolun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfeng","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bosen","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuedong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116885_bib1","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"10.1016\/j.jpba.2025.116885_bib3","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","article-title":"Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study","volume":"18","author":"von der Maase","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.jpba.2025.116885_bib4","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00432-021-03882-2","article-title":"Immunotherapy maintenance therapy for advanced urothelial carcinoma (aUC): a comprehensive review","volume":"148","author":"Carril-Ajuria","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jpba.2025.116885_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2095-4964(14)60038-8","article-title":"Three advantages of using traditional Chinese medicine to prevent and treat tumor","volume":"12","author":"Ling","year":"2014","journal-title":"J. Integr. Med."},{"issue":"5","key":"10.1016\/j.jpba.2025.116885_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.joim.2022.06.003","article-title":"Examining patterns of traditional Chinese medicine use in pediatric oncology: a systematic review, meta-analysis and data-mining study","volume":"20","author":"Lam","year":"2022","journal-title":"J. Integr. Med."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13020-023-00818-5","article-title":"Mechanisms of Xiaozheng decoction for anti-bladder cancer effects via affecting the GSK3\u03b2\/\u03b2-catenin signaling pathways: a network pharmacology-directed experimental investigation","volume":"18","author":"Zhuang","year":"2023","journal-title":"Chin. Med."},{"key":"10.1016\/j.jpba.2025.116885_bib8","doi-asserted-by":"crossref","first-page":"1260683","DOI":"10.3389\/fphar.2023.1260683","article-title":"Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2025.116885_bib9","first-page":"1007","article-title":"Clinical stusy of effects of Qici Sanling decoction on postoperative recurrence rate of patients with non-muscle invasive bladder cancer","volume":"52","author":"Yu","year":"2018","journal-title":"Shanghai J. Tradit. Chin. Med."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/13880209.2019.1626449","article-title":"Qici Sanling decoction suppresses bladder cancer growth by inhibiting the Wnt\/\u0392-catenin pathway","volume":"57","author":"Gong","year":"2019","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.jpba.2025.116885_bib11","first-page":"7985468","article-title":"Qici Sanling decoction suppresses glutamine consumption and bladder cancer cell growth through inhibiting c-Myc expression","author":"Chen","year":"2022","journal-title":"J. Oncol."},{"issue":"5","key":"10.1016\/j.jpba.2025.116885_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/bib\/bbt035","article-title":"Systems pharmacology in drug discovery and therapeutic insight for herbal medicines","volume":"15","author":"Huang","year":"2014","journal-title":"Brief. Bioinf."},{"issue":"3","key":"10.1016\/j.jpba.2025.116885_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.tranon.2015.04.002","article-title":"Drug-resistant urothelial cancer cell lines display diverse sensitivity profiles to potential second-line therapeutics","volume":"8","author":"Vallo","year":"2015","journal-title":"Transl. Oncol."},{"issue":"4","key":"10.1016\/j.jpba.2025.116885_bib14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","article-title":"The genome sequence archive family: toward explosive data growth and diverse data types","volume":"19","author":"Chen","year":"2021","journal-title":"Genom. Proteom. Bioinf."},{"issue":"D1","key":"10.1016\/j.jpba.2025.116885_bib15","doi-asserted-by":"crossref","first-page":"D27","DOI":"10.1093\/nar\/gkab951","article-title":"China National center for bioinformation in 2022","volume":"50","author":"Database Resources of the National Genomics Data Center","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.jpba.2025.116885_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"10.1016\/j.jpba.2025.116885_bib18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41388-024-03003-6","article-title":"Downregulation of UBB potentiates SP1\/VEGFA-dependent angiogenesis in clear cell renal cell carcinoma","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib19","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"4 Pt 1","key":"10.1016\/j.jpba.2025.116885_bib20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0022-5347(05)64522-3","article-title":"Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer","volume":"168","author":"Wheeler","year":"2002","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9440(10)64513-0","article-title":"Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas","volume":"157","author":"K\u00f6mhoff","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.jpba.2025.116885_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1940-6207.CAPR-12-0358","article-title":"Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo","volume":"6","author":"Cekanova","year":"2013","journal-title":"Cancer Prev. Res."},{"issue":"21","key":"10.1016\/j.jpba.2025.116885_bib23","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jpba.2025.116885_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.07.013","article-title":"SnapShot: bladder cancer","volume":"34","author":"Hurst","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12943-022-01680-z","article-title":"Biological and pharmacological roles of m6A modifications in cancer drug resistance","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"issue":"7378","key":"10.1016\/j.jpba.2025.116885_bib27","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/480S82a","article-title":"TCM: made in China","volume":"480","author":"Cheung","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jpba.2025.116885_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.fitote.2013.10.010","article-title":"Synergy effects of herb extracts: pharmacokinetics and pharmacodynamic basis","volume":"92","author":"Yang","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jpba.2025.116885_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116565","article-title":"The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review","volume":"314","author":"Wu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jpba.2025.116885_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110142","article-title":"The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis","volume":"127","author":"Yan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jpba.2025.116885_bib31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12906-023-04174-7","article-title":"Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme","volume":"23","author":"Liang","year":"2023","journal-title":"BMC Complement Med. Ther."},{"issue":"5","key":"10.1016\/j.jpba.2025.116885_bib32","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"242","key":"10.1016\/j.jpba.2025.116885_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008455","article-title":"COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models","volume":"6","author":"Xu","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"19","key":"10.1016\/j.jpba.2025.116885_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231910996","article-title":"Allyl-, Butyl- and Phenylethyl-isothiocyanate modulate Akt-mTOR and Cyclin-CDK signaling in Gemcitabine- and Cisplatin-resistant bladder cancer cell lines","volume":"23","author":"Rutz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jpba.2025.116885_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/nu14020369","article-title":"Olive mill wastewater inhibits growth and proliferation of Cisplatin- and Gemcitabine-resistant bladder cancer cells in vitro by down-regulating the Akt\/mTOR-signaling pathway","volume":"14","author":"Rutz","year":"2022","journal-title":"Nutrients"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:18Z","timestamp":1762308978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"alternative-id":["S0731708525002262"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116885","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated network pharmacology and RNA sequencing analysis to reveal the mechanisms of Qici Sanling decoction in the treatment of gemcitabine resistant bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116885"}}